What is WW International, Inc.'s market cap?

WW International, Inc. (WW) has a market capitalization of $138.5M and trades on NASDAQ.

What is WW International, Inc.'s revenue and profitability?

WW International, Inc. generated $539.1M in trailing twelve-month revenue with a net loss of $1.2B, representing a net margin of -23.2%. Gross margin stands at 71.0%. These figures are based on the Q1 2026 filing.

Who are WW International, Inc.'s competitors?

WW International, Inc.'s key competitors include Hims & Hers Health, Eli Lilly, Medifast, Inc., and others. These companies compete in similar markets and product categories.

Who does WW International, Inc. partner with?

WW International, Inc.'s notable partners include Cleveland Clinic, Pvolve, Bank of America, and others.

What subsidiaries does WW International, Inc. have?

WW International, Inc.'s subsidiaries include Weekend Health, Inc. (Sequence).

Where is WW International, Inc. headquartered?

WW International, Inc. is headquartered in United States of America and employs approximately 4,850 people. It has been publicly traded since 2025.

WW International, Inc.

WW International is a global leader in weight management and health services, providing science-based programs that integrate behavioral science, community support, and clinical interventions.

Market cap

$138.48M-96.4%

Revenue$539.1M-31.4%

Net income-$1.2B-1,189%

EPS (diluted)-$25.09-1,991%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

June 15, 2026

Revenue$168.3MBeat by $9.7M EPS-$5.20Miss by $2.75

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$159.1M

EPS estimate$0.89

Financials

Q1 2026

Income statement

See full

Revenue$168.3M-9.8%

Gross profit$118.7M-10.7%

Operating income-$30.4M-50.7%

Net income-$52.0M+28.4%

EPS (diluted)-$5.20-471%

Balance sheet

See full

Cash & equivalents$120.9M-48.9%

Total debt$468.2M-71.7%

Total equity$265.6M+122%

Total assets$881.1M+26.4%

Cash flow

See full

Operating cash flow-$33.5M-324%

Valuation & ratios

Valuation

See full

Market cap$138.48M-96.4%

Enterprise value$485.81M-88.2%

P/S0.3×—

Returns & leverage

See full

Debt / equity1.8×—

Current ratio1.2×+1.0×

Segments

By product

See full

Subscription Revenues Net$167.4M-9.6%

Behavioral Subscription Revenues$128.5M-17.5%

Clinical Subscription Revenues$38.8M+31.8%

Other Revenues Net$904.0K-35.0%

Competitors

By market cap

Eli Lilly$1.07T+47.2%

Hims & Hers Health$7.0B-46.7%

Herbalife$1.3B+27.2%

Omada Health$1.2B+15.7%

WW International, Inc.$138.5M-96.3%

Medifast$110.2M-31.0%

Mbio Pharmaceuticals, Inc.$63.0M-74.1%

Alaunos Therapeutics$4.7M-4.2%

By revenue growth

Omada Health+49.4%

Eli Lilly+47.4%

Hims & Hers Health+32.8%

Herbalife+3.7%

WW International, Inc.-31.4%

Medifast-36.3%

By net margin

Eli Lilly34.99%+12.3pp

Herbalife4.67%-1.0pp

Hims & Hers Health-0.559%-9.8pp

Medifast-5.79%-4.5pp

Omada Health-11.27%+17.5pp

WW International, Inc.-23.21%-216pp

Profile

WW International is a global leader in weight management and health services, providing science-based programs that integrate behavioral science, community support, and clinical interventions. The company offers a holistic weight health platform that combines digital tools, personal coaching, and medical weight-loss solutions, including access to GLP-1 medications through its clinical network. Its core value proposition centers on sustainable health outcomes through accountability, personalized nutrition, and evidence-based medical care.

Competitive position

A leading global weight management brand with over 60 years of history, distinguished by its extensive peer-reviewed clinical research and integrated medical-behavioral model.

GeographiesUnited States, Global

Customer segmentsHealth-conscious consumers, Patients with obesity, Enterprise employees, Individuals with chronic conditions

Business modelSubscription, Direct-to-Consumer (DTC), B2B2C, Telemedicine

SuppliersPharmaceutical manufacturers, Cloud infrastructure providers, Licensed medical professionals, Digital advertising platforms

CustomersRetail consumers, Corporate employers, Insurance payers, Health systems

CountryUnited States of America

Listed2025

Employees4.9K

CEOFelicia DellaFortuna

SectorConsumer Cyclical

IndustryPersonal Products & Services

Websitecorporate.ww.com

FilingsSEC EDGAR

Ask your AI about WW International, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is WW International, Inc.'s market cap?: WW International, Inc. (WW) has a market capitalization of $138.5M and trades on NASDAQ.
What is WW International, Inc.'s revenue and profitability?: WW International, Inc. generated $539.1M in trailing twelve-month revenue with a net loss of $1.2B, representing a net margin of -23.2%. Gross margin stands at 71.0%. These figures are based on the Q1 2026 filing.
Who are WW International, Inc.'s competitors?: WW International, Inc.'s key competitors include Hims & Hers Health, Eli Lilly, Medifast, Inc., and others. These companies compete in similar markets and product categories.
Who does WW International, Inc. partner with?: WW International, Inc.'s notable partners include Cleveland Clinic, Pvolve, Bank of America, and others.
What subsidiaries does WW International, Inc. have?: WW International, Inc.'s subsidiaries include Weekend Health, Inc. (Sequence).
Where is WW International, Inc. headquartered?: WW International, Inc. is headquartered in United States of America and employs approximately 4,850 people. It has been publicly traded since 2025.